The costs of home care (HC) programs may be tailored to the specific needs of patients with hematological malignancies. The aim of this study was to analyze the use of resources and the costs of a program of HC for four different prognostic groups of patients subdivided according to disease status. Over 2 years, 144 patients with hematological malignancies were assisted at home. Patients were subdivided according to disease status and life expectancy in the following groups: (i) terminal phase, with a life expectancy of 3 months or less; (ii) advanced phase, with a life expectancy of 6 months or less; (iii) chronic phase, with a life expectancy of more than 6 months; (iv) discharged early from the hospital with curable disease, following anticancer chemotherapy. Median mean monthly costs (MMC) in Euro (€) have been compared with the costs of hospitalization (DRG). Among the 4 groups of patients, those discharged early and in terminal phase required the highest mean monthly number of home visits (27.2 and 24.1), transfusions (6.1 and 6.8) and days of care (22.8 and 19.7) respectively. MMC were affected by the following variables: disease status and transfusion requirements. MMC for terminal patients (4,232.50€) and those discharged early (3,986.40€) were higher than those for advanced (2,303.80€) and chronic patients (1,488,30€). The cost of HC was lower than the corresponding DRG charges, but exceeded the district fares for HC of cancer patients. In hematological patients, the costs of HC differ according to disease status and transfusion requirements. For some categories of patients, costs of HC are lower than those of hospitalization, although higher than the current national fares for HC programs. ©2007 Ferrata Storti Foundation.

Cost analysis of a domiciliary program of supportive and palliative care for patients with hematologic malignancies / C., Cartoni; G. A., Brunetti; G. M., D'Elia; M., Breccia; P., Niscola; M. G., Marini; A., Nastri; Alimena, Giuliana; Mandelli, Franco; Foa, Roberto. - In: HAEMATOLOGICA. - ISSN 0390-6078. - STAMPA. - 92:5(2007), pp. 666-673. [10.3324/haematol.10324]

Cost analysis of a domiciliary program of supportive and palliative care for patients with hematologic malignancies

M. Breccia;ALIMENA, Giuliana;MANDELLI, Franco;FOA, Roberto
2007

Abstract

The costs of home care (HC) programs may be tailored to the specific needs of patients with hematological malignancies. The aim of this study was to analyze the use of resources and the costs of a program of HC for four different prognostic groups of patients subdivided according to disease status. Over 2 years, 144 patients with hematological malignancies were assisted at home. Patients were subdivided according to disease status and life expectancy in the following groups: (i) terminal phase, with a life expectancy of 3 months or less; (ii) advanced phase, with a life expectancy of 6 months or less; (iii) chronic phase, with a life expectancy of more than 6 months; (iv) discharged early from the hospital with curable disease, following anticancer chemotherapy. Median mean monthly costs (MMC) in Euro (€) have been compared with the costs of hospitalization (DRG). Among the 4 groups of patients, those discharged early and in terminal phase required the highest mean monthly number of home visits (27.2 and 24.1), transfusions (6.1 and 6.8) and days of care (22.8 and 19.7) respectively. MMC were affected by the following variables: disease status and transfusion requirements. MMC for terminal patients (4,232.50€) and those discharged early (3,986.40€) were higher than those for advanced (2,303.80€) and chronic patients (1,488,30€). The cost of HC was lower than the corresponding DRG charges, but exceeded the district fares for HC of cancer patients. In hematological patients, the costs of HC differ according to disease status and transfusion requirements. For some categories of patients, costs of HC are lower than those of hospitalization, although higher than the current national fares for HC programs. ©2007 Ferrata Storti Foundation.
2007
hematological malignancies; home care; palliative care; supportive care
01 Pubblicazione su rivista::01a Articolo in rivista
Cost analysis of a domiciliary program of supportive and palliative care for patients with hematologic malignancies / C., Cartoni; G. A., Brunetti; G. M., D'Elia; M., Breccia; P., Niscola; M. G., Marini; A., Nastri; Alimena, Giuliana; Mandelli, Franco; Foa, Roberto. - In: HAEMATOLOGICA. - ISSN 0390-6078. - STAMPA. - 92:5(2007), pp. 666-673. [10.3324/haematol.10324]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/236187
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 31
  • ???jsp.display-item.citation.isi??? 27
social impact